Di Minno G - Search Results

1

Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders.

Di Minno G, Perno CF, Tiede A, Navarro D, Canaro M, Güertler L, Ironside JW. Di Minno G, et al. Blood Rev. 2016 Jan;30(1):35-48. doi: 10.1016/j.blre.2015.07.004. Epub 2015 Jul 20. Blood Rev. 2016. PMID: 26381318 Free PMC article. Review.

2

Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats.

Di Minno G, Canaro M, Ironside JW, Navarro D, Perno CF, Tiede A, Guertler L. Di Minno G, et al. Semin Thromb Hemost. 2013 Oct;39(7):779-93. doi: 10.1055/s-0033-1354420. Epub 2013 Sep 12. Semin Thromb Hemost. 2013. PMID: 24030344 Review.

3

Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice.

Di Minno G, Canaro M, Ironside JW, Navarro D, Perno CF, Tiede A, Gürtler L. Di Minno G, et al. Haematologica. 2013 Oct;98(10):1495-8. doi: 10.3324/haematol.2013.084145. Haematologica. 2013. PMID: 24091928 Free PMC article. No abstract available.

4

Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?

Di Minno G, Navarro D, Perno CF, Canaro M, Gürtler L, Ironside JW, Eichler H, Tiede A. Di Minno G, et al. Ann Hematol. 2017 Aug;96(8):1253-1270. doi: 10.1007/s00277-017-3028-4. Epub 2017 Jun 18. Ann Hematol. 2017. PMID: 28624906 Free PMC article. Review.

5

Convalescent plasma for administration of passive antibodies against viral agents.

Di Minno G, Mannucci PM, Ironside JW, Perno CF, Gürtler L, Aledort L. Di Minno G, et al. Haematologica. 2020 Dec 1;105(12):2710-2715. doi: 10.3324/haematol.2020.267427. Haematologica. 2020. PMID: 33256373 Free PMC article. No abstract available.

6

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry.

Baudo F, Collins P, Huth-Kühne A, Lévesque H, Marco P, Nemes L, Pellegrini F, Tengborn L, Knoebl P; EACH2 registry contributors. Baudo F, et al. Blood. 2012 Jul 5;120(1):39-46. doi: 10.1182/blood-2012-02-408930. Epub 2012 May 22. Blood. 2012. PMID: 22618709 Free article.

7

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Collins P, Baudo F, Knoebl P, Lévesque H, Nemes L, Pellegrini F, Marco P, Tengborn L, Huth-Kühne A; EACH2 registry collaborators. Collins P, et al. Blood. 2012 Jul 5;120(1):47-55. doi: 10.1182/blood-2012-02-409185. Epub 2012 Apr 18. Blood. 2012. PMID: 22517903 Free PMC article.

8

International recommendations on the diagnosis and treatment of acquired hemophilia A.

Tiede A, Collins P, Knoebl P, Teitel J, Kessler C, Shima M, Di Minno G, d'Oiron R, Salaj P, Jiménez-Yuste V, Huth-Kühne A, Giangrande P. Tiede A, et al. Among authors: di minno g. Haematologica. 2020 Jul;105(7):1791-1801. doi: 10.3324/haematol.2019.230771. Epub 2020 May 7. Haematologica. 2020. PMID: 32381574 Free PMC article.

9

Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of research.

Di Minno A, Spadarella G, Prisco D, Scalera A, Ricciardi E, Di Minno G. Di Minno A, et al. Among authors: di minno g. Blood Rev. 2015 Sep;29(5):335-43. doi: 10.1016/j.blre.2015.03.004. Epub 2015 Mar 31. Blood Rev. 2015. PMID: 25866382 Review.

10

Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.

Di Minno G. Di Minno G. Blood Rev. 2015 Jun;29 Suppl 1:S26-33. doi: 10.1016/S0268-960X(15)30005-9. Blood Rev. 2015. PMID: 26073366 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters